125 related articles for article (PubMed ID: 26755515)
1. Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study.
Bagatell R; McHugh K; Naranjo A; Van Ryn C; Kirby C; Brock P; Lyons KA; States LJ; Rojas Y; Miller A; Volchenboum SL; Simon T; Krug B; Sarnacki S; Valteau-Couanet D; von Schweinitz D; Kammer B; Granata C; Pio L; Park JR; Nuchtern J
J Clin Oncol; 2016 Mar; 34(7):740-6. PubMed ID: 26755515
[TBL] [Abstract][Full Text] [Related]
2. Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.
Barr EK; Laurie K; Wroblewski K; Applebaum MA; Cohn SL
Pediatr Blood Cancer; 2020 Oct; 67(10):e28390. PubMed ID: 32710697
[TBL] [Abstract][Full Text] [Related]
3. Solid tumors in children.
Kline NE; Sevier N
J Pediatr Nurs; 2003 Apr; 18(2):96-102. PubMed ID: 12720206
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma in Turkish children: experience of a single center.
Aydn GB; Kutluk MT; Yalçn B; Büyükpamukçu M; Kale G; Varan A; Akyüz C; Senocak ME; Büyükpamukçu N
J Pediatr Hematol Oncol; 2009 Jul; 31(7):471-80. PubMed ID: 19564739
[TBL] [Abstract][Full Text] [Related]
5. Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy.
Du L; Liu L; Zhang C; Cai W; Wu Y; Wang J; Lv F
J Pediatr Surg; 2014 Apr; 49(4):528-33. PubMed ID: 24726106
[TBL] [Abstract][Full Text] [Related]
6. The degree of tumor volume reduction during the early phase of induction chemotherapy is an independent prognostic factor in patients with high-risk neuroblastoma.
Yoo SY; Kim JS; Sung KW; Jeon TY; Choi JY; Moon SH; Son MH; Lee SH; Yoo KH; Koo HH
Cancer; 2013 Feb; 119(3):656-64. PubMed ID: 22952047
[TBL] [Abstract][Full Text] [Related]
7. Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma.
Caruso DA; Orme LM; Amor GM; Neale AM; Radcliff FJ; Downie P; Tang ML; Ashley DM
Cancer; 2005 Mar; 103(6):1280-91. PubMed ID: 15693021
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of delayed surgery in children with high-risk neuroblastoma.
Varan A; Kesik V; Şenocak ME; Kale G; Akyüz C; Büyükpamukçu M
J Cancer Res Ther; 2015; 11(2):268-71. PubMed ID: 26148582
[TBL] [Abstract][Full Text] [Related]
9. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
[TBL] [Abstract][Full Text] [Related]
10. A novel intensive induction therapy for high-risk neuroblastoma utilizing sequential peripheral blood stem cell collection and infusion as hematopoietic support.
Pradhan KR; Johnson CS; Vik TA; Sender LS; Kreissman SG
Pediatr Blood Cancer; 2006 Jun; 46(7):793-802. PubMed ID: 16206215
[TBL] [Abstract][Full Text] [Related]
11. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting.
Castel V; García-Miguel P; Cañete A; Melero C; Navajas A; Ruíz-Jiménez JI; Navarro S; Badal MD
Eur J Cancer; 1999 Apr; 35(4):606-11. PubMed ID: 10492635
[TBL] [Abstract][Full Text] [Related]
13. Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma.
Gustafson WC; Matthay KK
Expert Rev Neurother; 2011 Oct; 11(10):1411-23. PubMed ID: 21955198
[TBL] [Abstract][Full Text] [Related]
14. [Neuroblastoma in children under than 1 year of age].
Castel Sánchez V; Melero Moreno C; García-Miguel García-Rosados P; Navajas Gutiérrez A; Ruiz Jiménez JI; Navarro Fos S; Garín Valle JC; Galbe Sada M
An Esp Pediatr; 1997 Dec; 47(6):584-90. PubMed ID: 9575117
[TBL] [Abstract][Full Text] [Related]
15. Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma Registry.
Haupt R; Garaventa A; Gambini C; Parodi S; Cangemi G; Casale F; Viscardi E; Bianchi M; Prete A; Jenkner A; Luksch R; Di Cataldo A; Favre C; D'Angelo P; Zanazzo GA; Arcamone G; Izzi GC; Gigliotti AR; Pastore G; De Bernardi B
J Clin Oncol; 2010 May; 28(14):2331-8. PubMed ID: 20351331
[TBL] [Abstract][Full Text] [Related]
16. Pelvic neuroblastoma: low mortality and high morbidity.
Cruccetti A; Kiely EM; Spitz L; Drake DP; Pritchard J; Pierro A
J Pediatr Surg; 2000 May; 35(5):724-8. PubMed ID: 10813335
[TBL] [Abstract][Full Text] [Related]
17. Primary cerebral neuroblastoma. Long-term follow-up review and therapeutic guidelines.
Berger MS; Edwards MS; Wara WM; Levin VA; Wilson CB
J Neurosurg; 1983 Sep; 59(3):418-23. PubMed ID: 6886755
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study.
Di Giannatale A; Dias-Gastellier N; Devos A; Mc Hugh K; Boubaker A; Courbon F; Verschuur A; Ducassoul S; Malekzadeh K; Casanova M; Amoroso L; Chastagner P; Zwaan CM; Munzer C; Aerts I; Landman-Parker J; Riccardi R; Le Deley MC; Geoerger B; Rubie H
Eur J Cancer; 2014 Jan; 50(1):170-7. PubMed ID: 24021349
[TBL] [Abstract][Full Text] [Related]
19. Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma.
Sung KW; Lee SH; Yoo KH; Jung HL; Cho EJ; Koo HH; Lee SK; Kim J; Lim DH; Suh YL; Kim DW
Bone Marrow Transplant; 2007 Jul; 40(1):37-45. PubMed ID: 17468771
[TBL] [Abstract][Full Text] [Related]
20. Presenting features and treatment outcome of 78 Malaysian children with neuroblastoma.
Ng SM; Abdullah WA; Lin HP; Chan LL
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):149-53. PubMed ID: 10695803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
